Venture Life (#VLG) – proposed acquisition of Dentyl, £18.75m placing at 40p
- 2018-07-20 06:59:59
UK 05:15 Wednesday, 4 November 2026
Breaking news and expert analysis on fast-moving AIM and LSE listed shares
Hello Share Squirters. As I get older, I become more fearful about my health. Apart from a minor problem with the old prostate, I am not yet troubled by illness. But I think disaster may be around the corner, especially if I do not watch my diet and take preventative steps to slow down wearing out. So it would only be fair to consider buying shares in a company which fulfils those needs.
In this video from the storming success that was the 2017 UK Investor Show, Jerry Randall, CEO of Venture Life (VLG), is at the podium. And make sure that you keep April 21 2018 free for next year's UK Investor Show.
Venture Life (VLG) has a deal with Optibiotix (OPTI) so its management must be good chaps! Here is the head honcho in action at UK Investor Show. Enjoy.
Venture Life (VLG) is an AIM listed play on the ageing of the population. Its presentation at the UK Investor Show explains how it will profit from this and can be seen below.
